AstraZeneca chief executive Pascal Soriot isn’t confirming or denying reports that the UK’s largest listed company is considering moving its primary stock market listing from London to New York. Yet recent remarks reveal where the company’s future may lie. At AstraZeneca’s half-year results press conference, Soriot gushed about the US, “the country in our industry…
(Reuters) -AstraZeneca CEO Pascal Soriot is considering moving the company’s stock market listing to the U.S., the Times reported on Tuesday, citing multiple sources. Soriot has privately expressed a preference to shift the FTSE 100 company’s listing on multiple occasions and has also discussed relocating AstraZeneca’s domicile, the report said. The company declined to comment…
IonQ recently announced a significant achievement with Kipu Quantum, solving the most complex protein folding problem on a quantum computer. This breakthrough likely contributed to the company’s impressive 87% share price gain last quarter. The successful partnership with AstraZeneca and others to accelerate drug development, and collaborations with Toyota Tsusho and KISTI, bolster its global…